Skip to main content

Bitcoin consolidates at $50,000 with investors booking profits

To keep you updated, we send DeCrypt Weekly Update to your mailbox. In case, you wish to Unsubscribe Click Here
Powered by
DeCrypt Weekly Update

DeCrypt Weekly Update

Sat, Feb 24, 2024 | 10:27 AM IST
Bitcoin consolidates at $50,000 with investors booking profits

Hello Reader,

During the past week, Bitcoin experienced a surge, reaching the $53,000 mark, but is currently undergoing consolidation around the $50,000 level, primarily due to an uptick in profit booking. Despite facing bearish pressure, Bitcoin remains resilient above the crucial $50,000 threshold, indicating a prevailing optimism among most investors regarding its long-term prospects.

Meanwhile, Ethereum achieved a milestone by reaching the $3,000 level for the first time since April 2022. The speculation surrounding the potential approval of Ether exchange-traded funds (ETFs) in May played one of factors driving the recent surge in Ethereum's price. Read More
Edul Patel
About Edul PatelCo-Founder and CEO, Mudrex
CRYPTO TOP GAINERS
As on Feb 24, 2024 10:20 AM
Name LTP Vol (24h, Cr.) M.Cap (Cr.) Circ. Supply (Cr.)
Uniswap 1,00067.68% 21,526 75,531 75.38
Sushi 14031.43% 2,893 2,738 19.28
Siacoin 1.8220.72% 1,158 10,375 5,649.14
Flare 3.5220.46% 1,019 11,925 3,462.69
Shadow Token 13618.76% 33.83 2,172 15.99
dYdX 28317.93% 642 12,131 42.60
dYdX 28317.74% 3,056 8,541 30.06
WEEKLY TOP NEWS
Bitcoin consolidates at $50,000 with investors booking profitsBitcoin consolidates at $50,000 with investors booking profits
In a noteworthy development, Reddit has divulged its strategic investment in Bitcoin (BTC), aligning itself with the likes of MicroStrategy and Tesla in acquiring digital assets.
Top cryptocurrencies price on February 23: Bitcoin falls below $51,300; Internet Computer, Chainlink decline up to 4%Top cryptocurrencies price on February 23: Bitcoin falls below $51,300; Internet Computer, Chainlink decline up to 4%
At 11:30 p.m., Bitcoin was trading 0.5% lower at $51,229, while Ethereum was up 0.9% at $2,958. Meanwhile, the global cryptocurrency market cap fell 0.25% to around $1.95 trillion in the last 24 hours.
Bitcoin fair value still zero despite ETF inclusion: ECB BlogpostBitcoin fair value still zero despite ETF inclusion: ECB Blogpost
The blogpost on Thursday by Ulrich Bindseil, the Frankfurt institution's market infrastructure and payments director general, and Juergen Schaaf, an adviser, reiterates their long-held view that the digital currency presents risks to both society and the environment.
Advantages and disadvantages of cryptocurrencyAdvantages and disadvantages of cryptocurrency
Cryptocurrency in India offers financial inclusion, protection against inflation, remittance benefits, new investment avenues, fast transactions, and decentralization. However, it faces regulatory challenges, volatility, fraud risk, power consumption, and impact on traditional banking. The Supreme Court ruling and government regulations shape the future of cryptocurrency in India.
Crypto Price on February 22: Bitcoin holds near $52,000; BNB jumps over 7%Crypto Price on February 22: Bitcoin holds near $52,000; BNB jumps over 7%
​The cryptocurrency markets were trading marginally higher in Thursday's trade, led by Bitcoin, Ethereum, and BNB. The global cryptocurrency market cap surged 0.47% to around $1.97 trillion in the last 24 hours.
Texas crypto company sues SEC for 'overreach' on digital assetsTexas crypto company sues SEC for 'overreach' on digital assets
Fort Worth-based crypto company Lejilex and lobbying group Crypto Freedom Alliance of Texas (CFAT) claim the SEC has asserted jurisdiction over the industry without a "clear statutory mandate." Lejilex wants the court to rule that listing pre-existing tokens will not violate securities laws.
Crypto Price on February 21: Bitcoin stays below $52,000; altcoins tank up to 6%Crypto Price on February 21: Bitcoin stays below $52,000; altcoins tank up to 6%
Bitcoin was trading 0.3% lower at $51,814, while Ethereum was up 1.4% at $2,971. Meanwhile, the global cryptocurrency market cap fell 0.21% to around $1.97 trillion in the last 24 hours. Solana, Avalanche, Dogecoin, Polkadot, Toncoi, XRP, Internet Computer, and Shiba Inu fell up to 6%. While Ethereum and Tron surged up to 2%.
For More Insights Visit ETMarkets Crypto Corner
Thanks for reading. See you next Saturday with more interesting stories and updates. Follow us on Twitter and Facebook.
Liked it? Share it with your friends
whatuphate ithate it

PS : We'd love to hear from you. Reply to this mail & share your thoughts with us.

* If you do not want to receive this mailer, please unsubscribe here.

© 2024 Times Internet Limited

Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh
Post a Comment
Read More

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr
Post a Comment
Read More

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side
Post a Comment
Read More